CCXI
Ensign Peak Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-96,746
| Closed | -$2.4M | – | 2382 |
|
|
2022
Q2 | $2.4M | Buy |
96,746
+23,783
| +33% | +$589K | 0.01% | 744 |
|
|
2022
Q1 | $1.83M | Hold |
72,963
| – | – | ﹤0.01% | 925 |
|
|
2021
Q4 | $2.66M | Buy |
+72,963
| New | +$2.66M | 0.01% | 868 |
|
|
2021
Q2 | – | Sell |
-37,224
| Closed | -$1.91M | – | 1868 |
|
|
2021
Q1 | $1.91M | Hold |
37,224
| – | – | ﹤0.01% | 1139 |
|
|
2020
Q4 | $2.31M | Hold |
37,224
| – | – | 0.01% | 980 |
|
|
2020
Q3 | $2.04M | Buy |
37,224
+22,540
| +154% | +$1.24M | 0.01% | 961 |
|
|
2020
Q2 | $845K | Buy |
14,684
+3,058
| +26% | +$176K | ﹤0.01% | 1331 |
|
|
2020
Q1 | $467K | Buy |
11,626
+7,929
| +214% | +$318K | ﹤0.01% | 1408 |
|
|
2019
Q4 | $146K | Buy |
+3,697
| New | +$146K | ﹤0.01% | 1632 |
|